Cargando…
Comparison of 2 curative treatment options for very early hepatocellular carcinoma: Efficacy, recurrence pattern, and retreatment
Curative treatments for very early-stage hepatocellular carcinoma (HCC), defined as single HCC with a maximum diameter of <2 cm in patients with well-preserved liver function, consist of surgical resection or radiofrequency ablation (RFA). In this retrospective study, we compared the efficacy of...
Autores principales: | Kim, Tae Hyung, Chang, Jung Mi, Um, Soon Ho, Jee, Heejung, Lee, Yoo Ra, Lee, Han Ah, Yim, Sun Young, Han, Na Yeon, Lee, Jae Min, Choi, Hyuk Soon, Kim, Eun Sun, Yu, Young-Dong, Keum, Bora, Kim, Min Ju, An, Hyunggin, Park, Beom Jin, Seo, Yeon Seok, Kim, Dong-Sik, Yim, Hyung Joon, Cho, Sung Bum, Jeen, Yoon Tae, Lee, Hong Sik, Chun, Hoon Jai, Kim, Yun Hwan, Kim, Chang Duck |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616374/ https://www.ncbi.nlm.nih.gov/pubmed/31261600 http://dx.doi.org/10.1097/MD.0000000000016279 |
Ejemplares similares
-
Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients
por: Yim, Sun Young, et al.
Publicado: (2017) -
How Should We Assign Large Infiltrative Hepatocellular Carcinomas for Staging?
por: Lee, Yoo Jin, et al.
Publicado: (2020) -
Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B
por: Kim, Tae Hyung, et al.
Publicado: (2018) -
The HBV DNA cutoff value for discriminating patients with HBeAgnegative chronic hepatitis B from inactive carriers
por: Kim, Eun Sun, et al.
Publicado: (2011) -
Natural killer cell activity is a risk factor for the recurrence risk after curative treatment of hepatocellular carcinoma
por: Lee, Han Ah, et al.
Publicado: (2021)